研究单位：[1]Shanghai Jiao Tong University School of Medicine[2]Xuanwu Hospital,Beijing[3]Capital Medical University[4]Peking University First Hospital[5]Tianjin Medical University Cancer Institute and Hospital[6]The First Affiliated Hospital of Dalian Medical University[7]China Medical University,China[8]The first clinical college of harbin medical university[9]The Second Affiliated Hospital of Harbin Medical University[10]Shengjing Hospital[11]Jilin University[12]The people's hospital of Heilongjiang province[13]Eastern Hepatobiliary Surgery Hospital[14]Shanghai Changzheng Hospital[15]Shandong Provincial Hospital[16]Qilu Hospital of Shandong University[17]Air Force Military Medical University,China[18]Tang-Du Hospital[19]Qinghai People's Hospital[20]Affiliated Hospital of Qinghai University[21]First Affiliated Hospital of Chongqing Medical University[22]Daping Hospital and the Research Institute of Surgery of the Third Military Medical University[23]First People's Hospital of Kunming[24]Lanzhou university second hospital[25]Xi'an Central Hospital[26]The first people's hospital of Guiyang[27]Southwest Hospital,China[28]The First Affiliated Hospital of Kunming Medical College
研究目的：
Objective Primary:
Determine the objective response rate in patients with advanced gallbladder treated with new Chemotherapy regimen
Secondary:
Determine time to progression-free survival and overall survival of patients treated with this regimen.
Determine quality of life of patients treated with this regimen. Determine the toxicity of new chemotherapy regimen
